Pharmacology

High Dose Of Favipiravir Counters SARS-CoV-2 In Hamsters

The SARS-CoV-2 virus, the 2019 form of coronavirus that has caused the COVID-19 pandemic, has led to a rush of studies searching for a vaccine to prevent infection and testing existing drugs to see which one can reduce the amount of virus in infected peopl ...

Article - News Staff - Oct 13 2020 - 12:09pm

Like Most Supplement Purchasers, Believers Think Cannabidiol Is Medicine Despite No Evidence

Cannabidiol, a chemical found in marijuana plants, is enjoying a wave of financial success due to strange prescriptions for "medical" marijuana, which ended up overwhelmingly being obtained for recreation. Yet belief in medicinal properties remai ...

Article - News Staff - Oct 15 2020 - 4:20pm

Remdesivir Gets FDA Approval As First COVID-19 Treatment

After clinical trials showed the safety and efficacy of Veklury (remdesivir) in adult and pediatric patients 12 years of age and older, the U.S. Food and Drug Administration has approved the antiviral drug for the treatment of severe COVID-19- requiring ho ...

Article - News Staff - Oct 22 2020 - 4:49pm

Thanks Science: New Cancer Drugs Led To A Reduction In Mortality Of 24% In The US Since 2000

The COVID-19 pandemic has sent both political parties rushing to wrap themselves in the flag of science- even those voters who were historically more inclined to oppose vaccines and medicine and purchase organic food. They should have been on Team Science ...

Article - News Staff - Nov 9 2020 - 11:39am

Quick Positive Results For RNA-Based Pfizer And BioNTech CoVID-19 Vaccine Doesn't Mean It Was Rushed

Recently, Pfizer and BioNTech released promising preliminary results of their clinical Phase III trials with 40,000 participants for their RNA vaccine candidate. This report suggests 90% efficacy for protection against SARS-CoV-2, the virus which causes t ...

Article - Jenny Jongstra-Bilen - Nov 27 2020 - 6:01am

Large Multicenter Trial: Omega-3 Supplements Have No Benefit For Patients At Cardiac Risk, But Do Have Some Harm

Results from the STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia (STRENGTH) double-blind, randomized, multicenter trial from 2014 to 2020 found that in patients with high cardiovascular risk, supplements of Om ...

Article - News Staff - Dec 9 2020 - 5:19pm

Worried About Arsenic In Your Apple Juice? Thank Dr. Oz

Far be it from me to consider anything designated by Oprah Winfrey as, perhaps, maybe, not always evidence-based, but I had always hoped some skepticism was in order yet consistently instead found Oprah viewers were not only ready to believe, they were wil ...

Article - Hank Campbell - Dec 10 2020 - 10:51am

Bee Delightful, New Leaf Pharmaceuticals, And More Busted By FDA For Illegally Claiming Their CBD Products Can Treat Conditions

Cannabidiol (CBD(products are being illegally marketed for pets, including a product for use in the eye, and for various conditions in humans also, despite any evidence they can prevent, diagnose, mitigate, treat or cure various diseases. Shady hucksters h ...

Article - News Staff - Dec 22 2020 - 4:21pm

Vaping Flavor Chemicals In Huge Quantities Can Damage Heart Cells In A Dish, But Where Is The Human Relevance?

A new paper claims that people vaping instead of smoking are putting their hearts at risk but their study does not show that. Instead, they mixed chemicals in Petri dishes with heart cells and used mice. Both of those are fine exploratory experiments but t ...

Article - Hank Campbell - Jan 15 2021 - 10:52am

Ivermectin Is No Longer Banned For Reducing Mild COVID-19 And A Small Pilot Study Gives It Some Hope For Approval

The NIH Treatment Guidelines Panel recently changed ivermectin from firmly “against” to the neutral “neither for nor against” when it comes to mild COVID-19 treatment. Ivermectin, developed in 1975, led to the eradication of numerous parasitic diseases and ...

Article - News Staff - Jan 19 2021 - 9:52am